Latest News
All Times Eastern
- Bond yields steady before payrolls after week of big price gains
- These analysts say the office and apartment building worries after NYCB are like Groundhog Day — but do concede one issue
- Car loaded with gas in Kenya explodes and sets off inferno that injures more than 270, kills at least 33
- Barron's Energy Stocks Have Struggled. Why They Shine as Dividend Payers.
- Barron's Philip Morris Stock Stands to Get a Boost From Earnings
- Barron's Brazil Is Having a Great Time. 5 Stocks to Play.
- Barron's Boeing’s Troubles Aren’t Going Away. How to Profit From Its Problems.
- Barron's The 6% Commission for Home Sales Is Under Attack. Inside the Fight to Keep It Alive.
- Prosecutors weigh perjury charge for ex-Trump CFO Allen Weisselberg over civil fraud trial testimony
- Shares of China’s Landsea Green rise on plan to buy Texas homebuilder for $185 million
to be replaced
Revelation Biosciences Inc.
REVBUS
$
-0.08
-2.52%
Premarket
$
3.1000
Before Hours Volume:
3.98K
| Close | Chg | Chg % |
|---|---|---|
| $3.1800 | -5.6200 | -63.86% |
Volume: 2.55M
65 Day Avg: 167.29K
3.0300
Day Range
3.6399
3.0300
52 Week Range
320.3970
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
REVB Overview
Key Data
- Open $3.5400
- Day Range 3.0300 - 3.6399
- 52 Week Range 3.0300 - 320.3970
- Market Cap $1.85M
- Shares Outstanding 209.91K
- Public Float 206.77K
- Beta 1.26
- Rev. per Employee N/A
- P/E Ratio N/A
- EPS -$12.5747
- Yield N/A
- Dividend N/A
- Ex-Dividend Date N/A
- Short Interest 19.23K 01/12/24
- % of Float Shorted 9.30%
- Average Volume 167.29K
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings 1
Full Ratings
Dow Jumps 250 Points; Honeywell Issues Weak Forecast
on Benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
on Benzinga.com
Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations
on Benzinga.com
Nasdaq Surges 100 Points; US Jobless Claims Increase To 224,000
on Benzinga.com
Citi Is Souring on Qualcomm (QCOM) Stock
on InvestorPlace.com
PLUG Stock Pops as Plug Power Reaches Major Milestone
on InvestorPlace.com
Why Is Infobird (IFBD) Stock Down 31% Today?
on InvestorPlace.com
Why Is Revelation Biosciences (REVB) Stock Down 62% Today?
on InvestorPlace.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
on Benzinga.com
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
on InvestorPlace.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
on Benzinga.com
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
on InvestorPlace.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
on Benzinga.com
Revelation Biosciences Inc.
Revelation Biosciences, Inc. is a clinical-stage life sciences company, which focuses on the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. The company was founded on November 20, 2019 and is headquartered in San Diego, CA.